Agneta von Gegerfelt

Author

Frederick National Laboratory for Cancer Research

Also Known As

A von Gegerfelt, A. von Gegerfelt, Agneta von Gegerfelt

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Frederick National Laboratory for Cancer Research National Cancer Institute Center for Cancer Research Duke Medical Center Karolinska Institutet

About

Agneta von Gegerfelt is an author at Frederick National Laboratory for Cancer Research specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1K
2	Natural Sciences	1	1	118
3	Allergy	1	1	25
4	Biochemistry	1	1	118
5	Biomolecular Engineering	1	1	118

Agneta von Gegerfelt

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates E M Fenyö, Linda Morfeldt-Månson, Francesca Chiodi, Journal of Virology Viral ReplicationImmunologyHuman Immunodeficiency VirusImmunotherapyHuman Retrovirus	1988	436
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. P A Broliden, Agneta von Gegerfelt, P. Clapham, Proceedings of the National Academy of Sciences Amino AcidsViral ImmunityImmunologyMolecular BiologyViral Structural Protein	1992	118
Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation Margherita Rosati, Antonio Valentin, Rashmi Jalah, Vaccine VaccinationMucosal VaccinationDna VaccinationVaccine DevelopmentRhesus Macaques	2008	94
DNA Vaccines Expressing Different Forms of Simian Immunodeficiency Virus Antigens Decrease Viremia upon SIVmac251 Challenge Margherita Rosati, Agneta von Gegerfelt, Patricia Roth, Journal of Virology	2005	94
Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen Zdeněk Hel, Wen-Po Tsai, Arthur Thornton, The Journal of Immunology	2001	91
Autologous Neutralizing Antibodies Prevail in HIV-2 but Not in HIV-1 Infection Ewa Björling, Gabriella Scarlatti, Agneta von Gegerfelt, Virology Autoimmune DiseaseHuman RetrovirusImmunologyAntiviral ResponseAntibody Screening	1993	89
DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge Vainav Patel, Rashmi Jalah, Viraj Kulkarni, Proceedings of the National Academy of Sciences	2013	76
IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques Rashmi Jalah, Vainav Patel, Viraj Kulkarni, Human Vaccines & Immunotherapeutics	2012	72
Isolate-specific neutralizing antibodies in patients with progressive HIV-1-related disease Agneta von Gegerfelt, Jan Albert, Linda Morfeldt-Månson, Virology Primary ImmunodeficiencyMedicineHuman RetrovirusImmunologyChronic Viral Infection	1991	66
PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral Therapy Elena Bekerman, Joseph Hesselgesser, Brian Carr, Antimicrobial Agents and Chemotherapy Persistent Viral ReservoirAntiretroviral TherapyPd-1 BlockadeHuman RetrovirusImmunology	2019	59

Page 1